The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

qrxpharma.com

Founded Year

2002

Stage

Other Investors | Alive

About QRxPharma

QRx was formed in late 2002 with initial venture capital backing led by Innovation Capital, Nanyang Ventures, SpringRidge Ventures (US) and UniSeed. The companylisted on the ASX in May 2007.The Company has a development pipeline that includes acombination pain therapy in Phase III clinical trials,with others in preclinical development and discovery.

QRxPharma Headquarter Location

1/194 Miller Street

2060,

Australia

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

QRxPharma Patents

QRxPharma has filed 9 patents.

patents chart

Application Date

Grant Date

Title

Related Topics

Status

5/31/2012

1/13/2015

Analgesics, Phenols, Morphinans, Synthetic opioids, Opioids

Grant

Application Date

5/31/2012

Grant Date

1/13/2015

Title

Related Topics

Analgesics, Phenols, Morphinans, Synthetic opioids, Opioids

Status

Grant

Latest QRxPharma News

QRxPharma Ltd Strategic SWOT Analysis Review Published by Global Data Prices from USD $125

Apr 5, 2020

04:19 EDT 5 Apr 2020 | BioPortfolio Reports QRxPharma Ltd Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company's key employees, key competitors and major products and services. This uptotheminute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better. Scope Corporate strategy GlobalData's summarization of the company's business strategy. SWOT analysis A detailed analysis of the company's strengths, weakness, opportunities and threats. Company history Progression of key events associated with the company. Major products and services A list of major products, services and brands of the company. Key competitors A list of key competitors to the company. Key employees A list of the key executives of the company. Executive biographies A brief summary of the executives' employment history. Key operational heads A list of personnel heading key departments/functions. Important locations and subsidiaries A list of key locations and subsidiaries of the company, including contact details. Highlights QRxPharma Ltd QRxPharma develops and commercializes treatments for pain management and abuse prevention products. The company's product portfolio includes late and early stage clinical drug candidates. Its dual opioid product portfolio includes Moxduo IR Q8003, an immediate release oral capsule for the treatment of acute management of moderate to severe pain ; Moxduo IV Q8012, an intravenous formulation for moderate to severe hospitalbased pain; and Moxduo CR Q8011, a controlled release oral tablet being developed in Phase II clinical trial for the treatment of chronic pain. The company's abuse deterrent technology called Stealth Beadlets has been developed for controlled release Moxduo formulation. It has operations in the US and Australia. QRxPharma is headquartered in North Sydney, New South Wales, Australia. Reasons to Buy Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs. Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services and business strategy. Understand and respond to your competitors' business structure and strategies with GlobalData's detailed SWOT analysis. In this, the company's core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company. Examine potential investment and acquisition targets with this report's detailed insight into the company's strategic, business and operational performance. Note: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

QRxPharma Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

QRxPharma Rank

  • When was QRxPharma founded?

    QRxPharma was founded in 2002.

  • What is QRxPharma's latest funding round?

    QRxPharma's latest funding round is Other Investors.

  • Who are the investors of QRxPharma?

    Investors of QRxPharma include UniSeed and Innovation Capital Limited.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.